These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1720845)

  • 41. Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter.
    Hohnloser SH; Dorian P; Straub M; Beckmann K; Kowey P
    J Am Coll Cardiol; 2004 Jul; 44(1):99-104. PubMed ID: 15234416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of block by tedisamil of transient outward current in human ventricular subepicardial myocytes.
    Wettwer E; Himmel HM; Amos GJ; Li Q; Metzger F; Ravens U
    Br J Pharmacol; 1998 Oct; 125(4):659-66. PubMed ID: 9831899
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repetitive endocardial focal discharges during ventricular fibrillation with prolonged global ischemia in isolated rabbit hearts.
    Wu TJ; Lin SF; Hsieh YC; Chiu YT; Ting CT
    Circ J; 2009 Oct; 73(10):1803-11. PubMed ID: 19652397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Defibrillatory action of glibenclamide is independent from ATP-sensitive K+ channels and free radicals.
    Csonka C; Onody A; Csont T; Ferdinandy P
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):916-22. PubMed ID: 12775970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tedisamil in coronary disease: additional benefits in the therapy of atrial fibrillation?
    Opie LH
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8 Suppl 1():S33-7. PubMed ID: 12746750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of ventricular fibrillation in the isolated heart: the role of slow calcium channel activity under continuous perfusion.
    Amitzur G; Pogatz V; Novikov I; Kaplinsky E; Eldar M
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):16-28. PubMed ID: 10630729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of heart rate on the termination of electrically induced ventricular fibrillation in the isolated perfused rat heart.
    Arad M; Rogel S; Mahler Y; Uretzky G
    Basic Res Cardiol; 1988; 83(6):678-86. PubMed ID: 3223882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Further studies into the ECG effects of tedisamil (KC 8857) in rats.
    Howard PG; Abraham S; Courtice ID; Walker MJ
    Proc West Pharmacol Soc; 1989; 32():183. PubMed ID: 2780585
    [No Abstract]   [Full Text] [Related]  

  • 49. Limited antifibrillatory effectiveness of clinically relevant concentrations of class I antiarrhythmics in isolated perfused rat hearts.
    Farkas A; Curtis MJ
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):412-24. PubMed ID: 11862121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cellular electrophysiological effects of tedisamil in human atrial and ventricular fibers.
    Németh M; Virág L; Hála O; Varró A; Kovács G; Thormählen D; Papp JG
    Cardiovasc Res; 1996 Feb; 31(2):246-8. PubMed ID: 8730401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of tedisamil on cell communication, impulse propagation, and excitability of the failing heart.
    De Mello WC; Thormahlen D
    Eur J Pharmacol; 1999 May; 372(3):241-6. PubMed ID: 10395018
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Probability of induction and stabilization of ventricular fibrillation with epinephrine.
    Tovar OH; Bransford PP; Jones JL
    J Mol Cell Cardiol; 1998 Feb; 30(2):373-82. PubMed ID: 9515014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of propafenone on the median frequency of ventricular fibrillation in Langendorff perfused guinea-pig hearts.
    Eggenreich U; Fleischmann PH; Stark G; Wach P
    Cardiovasc Res; 1996 Jun; 31(6):926-31. PubMed ID: 8759248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart.
    Hearse DJ; Ferrari R; Sutherland FJ
    J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Susceptibility to ischemia-induced ventricular fibrillation in isolated female rat hearts varies moderately with estrous cycle stage.
    Hatcher AS; Clements-Jewery H
    J Pharmacol Toxicol Methods; 2013; 67(3):134-9. PubMed ID: 23357189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrophysiological mechanisms for the initiation and maintenance of ventricular fibrillation in nonischemic rabbit hearts.
    Watanabe Y; Toda H; Uchida H
    Heart Vessels Suppl; 1987; 2():69-87. PubMed ID: 3449506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
    Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
    Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycyrrhetinic Acid protects the heart from ischemia/reperfusion injury by attenuating the susceptibility and incidence of fatal ventricular arrhythmia during the reperfusion period in the rat hearts.
    Wu HJ; Yang JY; Jin M; Wang SQ; Wu DL; Liu YN; Yan X; Yang C; Zhang G; He J
    Cell Physiol Biochem; 2015; 36(2):741-52. PubMed ID: 26021262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of ventricular fibrillation versus monomorphic ventricular tachycardia during programmed stimulation. Role of premature beat conduction delay.
    Avitall B; McKinnie J; Jazayeri M; Akhtar M; Anderson AJ; Tchou P
    Circulation; 1992 Apr; 85(4):1271-8. PubMed ID: 1372847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tedisamil attenuates foetal transformation of myosin in the hypertrophied rat myocardium.
    Turcani M; Thormaehlen D; Rupp H
    Br J Pharmacol; 2004 Nov; 143(5):561-72. PubMed ID: 15466442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.